- Cboe files for first staking-based INJ ETF in U.S.
- Canary Capital targets altcoin ETF space with Injective staking proposal.
- Regulatory shift boosts chances for staking-enabled crypto ETFs approval.
The Cboe BZX Exchange has filed for the first staking-enabled exchange-traded fund (ETF) tied to Injective (INJ) in the United States. As an initiative filed by Canary Capital Group LLC, the proposal introduces the Canary Staked INJ ETF and seeks to introduce staking rewards at the ETF level.
This development marks a key step toward offering mainstream investors exposure to altcoins with built-in yield mechanisms. Through the ETF, institutions and retail traders would be able to enjoy Injective’s staking model without the requirement of managing their wallets or having to delegate tokens.
It was filed at a time when there had been an increased number of ETF applications due to the current U.S. administration under President Donald Trump. Crypto ETFs on spot have already been cleared by previous regulations, which have opened the door to Bitcoin and Ethereum. Attention is now drifting to altcoins such as Solana, XRP, and Injective.
Cboe filed an application, which was combined with the filing of the Invesco Galaxy Solana ETF. These twin forms are a harbinger of a wider attempt by asset managers to grab an early foothold in the new altcoin ETF marketplace.
Also Read: Here’s What 1,000 XRP Could Be Worth at The End of This Bull Cycle – Analyst Shares Insight
Staking Element Adds Institutional Appeal to INJ ETF
The proposed ETF’s inclusion of staking is a unique component that sets it apart from most previous crypto funds. In May, the SEC’s Division of Corporation Finance stated that certain staking models may not qualify as securities offerings.
This clarification enables issuers of ETFs to provide more clarity to explore products based on staking with greater legal confidence.
When staking is enabled, an ETF can provide an extra dimension of passive yield without compromising the safety and liquidity of an ordinary fund for investors. This would boost demand by a significant amount, as it goes to institutions that want long-term returns and not direct crypto exposure.
There is also increased interest in Injective in the market, with INJ currently trading at $14.83 and supported by levels at $12.75. At the upper Bollinger Band is the resistance of $15.97.
Supported by bullish technical indicators, the Relative Strength Index stands at 60.36, signaling increasing momentum. A resistance breakout may reach the 1.618 Fibonacci extension of $21.68 and, with more extreme breakouts, move up to $27.19 and $36.12.
Source: Tradingview
The Canary Staked INJ ETF could be the first to combine staking rewards with spot altcoin exposure in a U.S.-listed product. If approved, it would set a new precedent for how altcoins are packaged and accessed by mainstream investors.
Also Read: FaZe CEO Ricky Banks Quits After MLG Coin Collapse and Leaked Chat Drama
